Loading... Please wait...

OSAplex MK-7™ | 60 Pkt | XYMOGEN

Roll over to magnify and click to enlarge
  • Image 1
  • OSAplex MK-7™ Supplements Facts
Supports Overall Bone Health and Strength
  • OSAplex MK-7™ Label
Supports Overall Bone Health and Strength

Product Reviews

Write Review

This product hasn't received any reviews yet. Be the first to review this product!

$98.65
Brand:
XYMOGEN
SKU:
XYM43100-mem
Availability:
Processes & Shipped within 24 HR Except on Holidays & weekends. Our System will update you on your order status automatically.

Product Description

Xymogen OSAplex MK-7™ is a comprehensive, convenient, and cost-effective dietary supplement that supports healthy bones, cartilage, and ligaments. Each packet provides the following: two capsules containing a combination of microcrystalline hydroxyapatite concentrate (MCHC) from Ossopan 1100™, vitamin D3, and vitamin K2 along with one capsule of choline-stabilized orthosilicic acid (ch-OSA®‡).*

Bone is composed of a calcium-based mineral complex and an organic material known as collagen. A somewhat flexible and fibrous protein, collagen appears to be a key factor in a bone’s ability to withstand sudden impact. The quantity and health of collagen determines the bone’s “toughness,” while the mineral content determines its strength and stiffness.*

OSAplex MK-7 contains choline-stabilized orthosilicic acid, a well-absorbed form of silicon that has been clinically tested. Silicon-dependent enzymes link together single chains of amino acids to synthesize collagen fibers. The surfaces of these collagen fibers act as the binding sites for the MCHC. The more surface area available to the MCHC to bind to, the more flexible the bone.*

MCHC, a proprietary, standardized, and safe-source bone extract from New Zealand bovine, contains a crystalline calcium and phosphorus matrix in the ideal physiological ratio of 2:1, plus bioactive growth factors and type I collagen. As a source of calcium, MCHC contributes to the production and maintenance of bone structure, a function supported by vitamins D3 and K2.  Amino acids, glycosaminoglycans, and a broad range of essential trace elements are also present.*

Combine ch-OSA and MCHC with significant levels of vitamins D3 and K2, and the result is a unique package that addresses quantity and quality of bone, and supports overall bone strength and health.*

OSAplex MK-7™

  • Provide a Multifaceted Approach to Bone Maintenance and Strength*
  • Provide Foundational Support with Choline-Stabilized Orthosilicic Acid (ch-OSA®)*
  • Support Bone Collagen Formation, Bone Mineral Density, and Bone Calcium Binding Sites*
  • Provide a Complementary Combination of Micronutrients

Directions:

Consume the contents of one packet with a meal, one to two times daily, or as directed by your healthcare practitioner. Consult your healthcare practitioner prior to use. Individuals taking medication should discuss potential interactions with their healthcare practitioner. Consider total vitamin K intake (food + supplements) if you are taking blood-thinning medication. Present studies show that 45 mcg of MK-7 from VitaMK7™ daily is not likely to interfere with blood-thinning medicines. Do not use if tamper seal is damaged.

Does Not Contain:

Wheat, gluten, yeast, soy protein, dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.

Storage:

Keep closed in a cool, dry place out of reach of children.
 

Other Ingredients for Ossopan 1100 with vitamins D3 and K2 capsule:

HPMC (capsule), vegetable stearic acid, vegetable magnesium stearate, medium-chain triglycerides, and silica.
 

Other Ingredients for ch-OSA capsule:

Microcrystalline cellulose, HPMC (capsule), and purified water.

VitaMK7 is a trademark of Gnosis S.p.A.

† Microcrystalline Hydroxyapatite Concentrate

‡Choline-stabilized orthosilicic acid (ch-OSA) is a registered trademark of and manufactured by Bio Minerals n.v., Belgium. Produced under US patents 5,922,360; 7,968,528; and 8,771,757.